Meeting
2022 ASCO Genitourinary Cancers Symposium
Age-based assessment of cell-free DNA genomic profiles in metastatic castration-resistant prostate cancer (mCRPC).
Authors
Andrea Knox
Peter MacCallum cancer Centre, Melbourne, VIC, Australia
Andrea Knox , Heidi Fettke , Christine Hauser , Patricia Bukczynska , Nicole Ng , Siavash Foroughi , Lisa-Jane K. Graham , Kate Lynette Mahon , Winston Tan , Tiantian Zheng , Chao Dai , Pan Du , Shidong Jia , Lisa Horvath , Manish Kohli , Arun Azad , Edmond Michael Kwan , Amy Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 150)
DOI
10.1200/JCO.2022.40.6_suppl.150
Abstract #
150
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
5-hydroxymethylcytosine as a liquid biopsy biomarker in mCRPC.
First Author: Martin Sjöström
Poster
2020 Genitourinary Cancers Symposium
Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Santosh Gupta
Poster
2019 Genitourinary Cancers Symposium
Circulating tumor (ct) DNA-based genomic profile of prostate cancer (PCa) patients with elevated carcinoembryonic antigen (CEA).
First Author: Pannaga G. Malalur
Poster
2017 Genitourinary Cancers Symposium
Circulating tumor (ct)-DNA alterations in metastatic castration-resistant prostate cancer (mCRPC): Association with outcomes and evolution with therapy.
First Author: Guru Sonpavde